The Ste20-like kinase SLK promotes p53 transactivation and apoptosis

Andrey V Cybulsky1, Tomoko Takano, Julie Guillemette

  • 1Div. of Nephrology, Royal Victoria Hospital, 687 Pine Ave. West, Montreal, Quebec H3A1A1, Canada. andrey.cybulsky@mcgill.ca

Insights

The study reveals that SLK kinase promotes kidney injury recovery by activating p53. This activation enhances apoptosis following renal ischemia-reperfusion injury, highlighting a key molecular pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Renal Pathophysiology

Background:

  • Germinal center kinase SLK (Scratch-like kinase) activity increases during kidney development and after renal ischemia-reperfusion injury.
  • SLK is known to promote apoptosis through pathways involving apoptosis signal-regulating kinase-1 and p38 mitogen-activated protein kinase.
  • The role of p53 in the SLK-mediated apoptotic pathway remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of p53 as a potential effector of SLK in the context of renal ischemia-reperfusion injury.
  • To determine if SLK influences p53 transactivation and phosphorylation.
  • To examine the impact of SLK-induced p53 activity on apoptosis.

Main Methods:

  • Assessed p53 transactivation using a luciferase reporter assay with a p53 cis-acting enhancer element in COS-1 cells and glomerular epithelial cells (GECs).
  • Induced in vitro ischemia-reperfusion injury in GECs via chemical anoxia and glucose reexposure.
  • Analyzed p53 phosphorylation at specific serine residues (S33, S315) and utilized p53 mutants to identify key phosphorylation sites. Inhibited c-Jun N-terminal kinase (JNK) and p53 transactivation using pifithrin-alpha.

Main Results:

  • Overexpression of SLK stimulated p53 transactivational activity in both COS-1 cells and GECs.
  • In vitro ischemia-reperfusion injury increased p53 reporter activity in GECs, an effect amplified by SLK overexpression.
  • SLK induced p53 phosphorylation at S33 and S315; only the double S33A+S315A mutation abolished SLK-induced p53 activity. JNK inhibition attenuated SLK-induced p53 activity.
  • SLK overexpression enhanced apoptosis during in vitro ischemia-reperfusion, while a dominant-negative SLK mutant reduced it. Pifithrin-alpha inhibited apoptosis.

Conclusions:

  • SLK induces p53 phosphorylation at S33 and S315, leading to enhanced p53 transactivation.
  • The SLK-p53 pathway, particularly involving JNK signaling, plays a critical role in promoting apoptosis following renal ischemia-reperfusion injury.
  • Targeting the SLK-p53 interaction may offer a therapeutic strategy for mitigating kidney injury.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...